Bank of New York Mellon’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.7K | Hold |
10,403
| – | – | ﹤0.01% | 4223 |
|
|
2026
Q1 | $67.8K | Sell |
10,403
-2,327
| -18% | -$14.5K | ﹤0.01% | 4126 |
|
|
2025
Q4 | $72.8K | Sell |
12,730
-10,776
| -46% | -$66.5K | ﹤0.01% | 4123 |
|
|
2025
Q3 | $160K | Sell |
23,506
-192
| -0.8% | -$1.45K | ﹤0.01% | 4061 |
|
|
2025
Q2 | $213K | Sell |
23,698
-19,651
| -45% | -$116K | ﹤0.01% | 3957 |
|
|
2025
Q1 | $233K | Sell |
43,349
-192
| -0.4% | -$1.3K | ﹤0.01% | 3819 |
|
|
2024
Q4 | $324K | Buy |
43,541
+11,448
| +36% | +$94.1K | ﹤0.01% | 3742 |
|
|
2024
Q3 | $290K | Sell |
32,093
-7,018
| -18% | -$72.4K | ﹤0.01% | 3780 |
|
|
2024
Q2 | $415K | Buy |
39,111
+26,206
| +203% | +$279K | ﹤0.01% | 3678 |
|
|
2024
Q1 | $114K | Sell |
12,905
-4,877
| -27% | -$39.7K | ﹤0.01% | 4022 |
|
|
2023
Q4 | $121K | Hold |
17,782
| – | – | ﹤0.01% | 4054 |
|
|
2023
Q3 | $174K | Hold |
17,782
| – | – | ﹤0.01% | 3997 |
|
|
2023
Q2 | $86.1K | Hold |
17,782
| – | – | ﹤0.01% | 4104 |
|
|
2023
Q1 | $71.5K | Hold |
17,782
| – | – | ﹤0.01% | 4129 |
|
|
2022
Q4 | $68.6K | Hold |
17,782
| – | – | ﹤0.01% | 4182 |
|
|
2022
Q3 | $85K | Hold |
17,782
| – | – | ﹤0.01% | 4232 |
|
|
2022
Q2 | $81K | Hold |
17,782
| – | – | ﹤0.01% | 4271 |
|
|
2022
Q1 | $96K | Sell |
17,782
-11,895
| -40% | -$63.7K | ﹤0.01% | 4414 |
|
|
2021
Q4 | $180K | Hold |
29,677
| – | – | ﹤0.01% | 4310 |
|
|
2021
Q3 | $211K | Sell |
29,677
-407
| -1% | -$3.28K | ﹤0.01% | 4196 |
|
|
2021
Q2 | $252K | Sell |
30,084
-627
| -2% | -$5.4K | ﹤0.01% | 4022 |
|
|
2021
Q1 | $254K | Buy |
30,711
+16
| +0.1% | +$113 | ﹤0.01% | 3972 |
|
|
2020
Q4 | $198K | Sell |
30,695
-1,138
| -4% | -$7.18K | ﹤0.01% | 3980 |
|
|
2020
Q3 | $188K | Hold |
31,833
| – | – | ﹤0.01% | 3861 |
|
|
2020
Q2 | $223K | Buy |
+31,833
| New | +$233K | ﹤0.01% | 3769 |
|
|
2018
Q2 | – | Sell |
-11,653
| Closed | -$116K | – | 4308 |
|
|
2018
Q1 | $116K | Sell |
11,653
-1,726
| -13% | -$13.4K | ﹤0.01% | 4032 |
|
|
2017
Q4 | $88K | Hold |
13,379
| – | – | ﹤0.01% | 4123 |
|
|
2017
Q3 | $90K | Sell |
13,379
-8,549
| -39% | -$58.2K | ﹤0.01% | 4022 |
|
|
2017
Q2 | $158K | Hold |
21,928
| – | – | ﹤0.01% | 3941 |
|
|
2017
Q1 | $120K | Hold |
21,928
| – | – | ﹤0.01% | 3986 |
|
|
2016
Q4 | $109K | Sell |
21,928
-1,387
| -6% | -$6.23K | ﹤0.01% | 4017 |
|
|
2016
Q3 | $96K | Sell |
23,315
-3,987
| -15% | -$17.5K | ﹤0.01% | 4052 |
|
|
2016
Q2 | $137K | Buy |
27,302
+11
| +0% | +$52 | ﹤0.01% | 3987 |
|
|
2016
Q1 | $140K | Hold |
27,291
| – | – | ﹤0.01% | 3891 |
|
|
2015
Q4 | $176K | Sell |
27,291
-5
| -0% | -$33 | ﹤0.01% | 3897 |
|
|
2015
Q3 | $161K | Buy |
27,296
+5
| +0% | +$22 | ﹤0.01% | 3972 |
|
|
2015
Q2 | $114K | Buy |
27,291
+912
| +3% | +$3.71K | ﹤0.01% | 4017 |
|
|
2015
Q1 | $104K | Sell |
26,379
-2
| -0% | -$7 | ﹤0.01% | 4033 |
|
|
2014
Q4 | $83K | Buy |
26,381
+2
| +0% | +$6 | ﹤0.01% | 4088 |
|
|
2014
Q3 | $85K | Hold |
26,379
| – | – | ﹤0.01% | 4081 |
|
|
2014
Q2 | $101K | Buy |
26,379
+177
| +0.7% | +$678 | ﹤0.01% | 3991 |
|
|
2014
Q1 | $111K | Hold |
26,202
| – | – | ﹤0.01% | 3966 |
|
|
2013
Q4 | $93K | Sell |
26,202
-133
| -0.5% | -$497 | ﹤0.01% | 4031 |
|
|
2013
Q3 | $106K | Sell |
26,335
-19
| -0.1% | -$72 | ﹤0.01% | 3944 |
|
|
2013
Q2 | $94K | Buy |
+26,354
| New | +$103K | ﹤0.01% | 3939 |
|
Other funds holding ULBI
THC
TA
MWM
Bank of New York Mellon's ULBI Position: Q2 2026 in Review
Bank of New York Mellon held its Ultralife (ULBI) position steady in Q2 2026 at 10,403 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4223.
Bank of New York Mellon first reported a position in ULBI in Q2 2013 and has held it in 45 quarters since. The position peaked at $415K in Q2 2024. 31 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.
- Bank of New York Mellon held 10,403 shares of Ultralife worth $65.7K as of Q2 2026.
- Bank of New York Mellon left its Ultralife share count unchanged in Q2 2026.
- Ultralife made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4223 holding.
- Bank of New York Mellon first reported a position in Ultralife in Q2 2013 and has held it in 45 quarters since.
- Bank of New York Mellon's Ultralife position peaked at $415K in Q2 2024.
- 31 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.